Damascus, Jul 31 (Prensa Latina) Syria and Cuba on Wednesday ratified their willingness to continue working to consolidate and expand collaboration in the pharmaceutical sector.
In statements to Prensa Latina, Syrian Deputy Minister of Health Habib Aboud described as important and successful the working visit to Syria by a delegation from the Biotechnology and Pharmaceutical Industries Business Group (BioCubaFarma).
He explained that ‘the talks paved the way to to broaden the prospects for collaboration in the field of drug exchange and technology transfer in order to manufacture Cuban medicines in Syria’.
Technology transfer is a promising issue, as it would help to make the presence of Cuban medicines stronger in the Syrian market and throughout the region,’ said the deputy minister.
On the other hand, he affirmed that Cuba has always had an honorable position regarding Syria, and the historic relations between the two countries had a positive impact during the unjust terrorist war that Syria is going through.
Thanks to friends in Cuba, in recent years we have been able to import Cuban medicines that meet some of Syria’s needs,’ he said.
For his part, the head of the Cuban delegation, Normando Iznaga Escobar, who is the Commercial and Business director of BioCubaFarma, said that the visit has confirmed that there are ideal conditions in Syria to expand collaboration, from both the academic and business points of view.
In statements to Prensa Latina, Iznaga explained that Syria has very good pharmaceutical companies, with very good conditions and good standards, which would help joint production to distribute Cuban medicines in Syria and the entire region.
The BioCubaFarma delegation concluded a working visit to Syria at the invitation of local health authorities.
Cuba has been supplying vaccines and medicines to Syria over the past few years, in a friendly initiative and expression of solidarity with this nation, which is facing a ferocious war imposed for more than eight years by the United States and its allies.